GOT1 and colorectal carcinoma: Aside from ME1, which showed a modest but statistically significant higher expression in CRC, the GOT1-pathway components examined were expressed at similar levels in the PDA and CRC cells [64] (Fig. 1l, Additional file 1: Figure S2f).